Appropriate candidates for statin use in heart failure

참고문헌 (38)

1. Dahl CP, "Increased expression of LIGHT", TNFSF14 and its receptors in experimental and clinical heart failure, 2008, pp.10, 352~359
2. McMurray JJ, "ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC", Eur Heart J, 33, pp.1787~1847 (2012)
3. Writing Committee Members, "2013 ACCF", AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation, Circulation, pp.2013, 128[DOI]
4. Laribi S, "Trends in death attributed to heart failure over the past two decades in Europe", Eur J Heart Fail, 14, pp.234~239 (2012)
5. Braunwald E, "Heart failure", JACC Heart Fail, 1, pp.1~20 (2013)
6. Levine B, "Elevated circulating levels of tumor necrosis factor in severe chronic heart failure", N Engl J Med, 323, pp.236~241 (1990)
7. Hambrecht R, "Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure", Circulation, 98, pp.2709~2715 (1998)
8. Tousoulis D, "Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure", Int J Cardiol, 100, pp.347~353 (2005)
9. Hedayat M, "Proinflammatory cytokines in heart failure: double-edged swords", Heart Fail Rev, 15, pp.543~562 (2010)
10. El-Menyar AA, "Cytokines and myocardial dysfunction:state of the art", J Card Fail, 14, pp.61~74 (2008)
11. Chung ES, "Anti-TNF Therapy Against Congestive Heart Failure Investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial", Circulation, 107, pp.3133~3140 (2003)
12. Mann DL, "Targeted anticytokine therapy in patients with chronic heart failure:results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)", Circulation, 109, pp.1594~1602 (2004)
13. Yoshimura T, "Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells", Pharmacology, 54, pp.144~152 (1997)
14. Feldman AM, "AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression", Circulation, 99, pp.1397~1399 (1999)
15. Matsumori A, "Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure", Circulation, 89, pp.955~958 (1994)
16. Matsumori A, "Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: a possible mechanism for its effect in heart failure", Circulation, 96, pp.1386~1389 (1997)
17. Matsumori A, "Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain", Circulation, 96, pp.1501~1506 (1997)
18. Ammann P, "Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency", J Clin Invest, 99, pp.1699~1703 (1997)
19. Cholesterol Treatment Trialists’ (CTT) Collaboration, "Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials", Lancet, 376, pp.1670~1681 (2010)
20. Laufs U, "Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors", Circulation, 97, pp.1129~1135 (1998)
21. Tousoulis D, "Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure", Atherosclerosis, 178, pp.359~363 (2005)
22. Bellosta S, "HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages", Arterioscler Thromb Vasc Biol, 18, pp.1671~1678 (1998)
23. Oi S, "Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neo natal rat heart cells", Eur J Pharmacol, 376, pp.139~148 (1999)
24. Gastelurrutia P, "Statins in heart failure: the paradox between large randomized clinical trials and real life", Mayo Clin Proc, 87, pp.555~560 (2012)
25. Sola S, "Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure", J Am Coll Cardiol, 47, pp.332~337 (2006)
26. Mozaffarian D, "Statin therapy is associated with lower mortality among patients with severe heart failure", Am J Cardiol, 93, pp.1124~1129 (2004)
27. Gissi-HF Investigators, "Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial", Lancet, 372, pp.1231~1239 (2008)
28. Kjekshus J, "Rosuvastatin in older patients with systolic heart failure", N Engl J Med, 357, pp.2248~2261 (2007)
29. Barrios V, "Rosuvastatin and cardiovascular continuum when time is important", J Am Coll Cardiol, 55, pp.1645~1646 (2010)
30. Barrios V, "Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA", Expert Rev Cardiovasc Ther, 7, pp.1317~1327 (2009)
31. Cleland JG, "Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin:a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)", J Am Coll Cardiol, 54, pp.1850~1859 (2009)
32. Athyros VG, "Statins and heart failure", J Am Coll Cardiol, 55, pp.1644~1645 (2010)
33. Khush KK, "Effect of highdose atorvastatin on hospitalizations for heart failure:subgroup analysis of the Treating to New Targets (TNT)study", Circulation, 115, pp.576~583 (2007)
34. Tousoulis D, "Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure", Atherosclerosis, 227, pp.367~372 (2013)
35. Nezasa K, "Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin", Drug Metab Dispos, 30, pp.1158~1163 (2002)
36. Bonsu KO, "Statins in heart failure: do we need another trial?", Vasc Health Risk Manag, 9, pp.303~319 (2013)
37. 이해영, "Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study", The Korean Journal of Internal Medicine, 29(6), pp.754~763 (2014), 대한내과학회[DOI]
38. Ramasubbu K, "Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy", J Am Coll Cardiol, 51, pp.415~426 (2008)

관련 논문AI추천